| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/15/1989 | WO1989005156A1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 06/15/1989 | WO1989005155A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells |
| 06/15/1989 | WO1989005153A1 Kidney growth accelerator |
| 06/15/1989 | WO1989005151A1 High integrity liposomes and method of preration and use |
| 06/15/1989 | WO1989005150A1 Conformationally stabilized cell adhesion peptides |
| 06/15/1989 | WO1989005149A1 Methyl cellulose pharmaceutical composition |
| 06/15/1989 | WO1989005148A1 A method of inhibiting platelet dependent arterial thrombosis |
| 06/15/1989 | WO1989005147A1 New anti-inflammatory agents |
| 06/15/1989 | WO1989005139A1 Medicinal preparation comprising the association of colistin, tobramycin and amphotericin b administered by atomization |
| 06/15/1989 | WO1989004875A3 Characterization and detection of sequences associated with autoimmune diseases |
| 06/14/1989 | EP0320495A1 Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof |
| 06/14/1989 | EP0320366A1 Monoclonal antibodies against phospholipase A2 from the venom of snakes of the families Elapides and Hidrophides, methods for their preparation and their use in detecting poisoning caused by these snake families |
| 06/14/1989 | EP0320289A1 Methods and compositions for the production of haemophilus influenzae type B major outer membrane protein antigens |
| 06/14/1989 | EP0320267A2 Glycoprotein growth modulation materials |
| 06/14/1989 | EP0320207A2 Methods and compositions for activating the human insulin receptor kinase |
| 06/14/1989 | EP0320205A2 Renin inhibiting dipeptides, their preparation and compositions containing them |
| 06/14/1989 | EP0320204A2 Renin inhibiting dipeptides, their preparation and compositions containing them |
| 06/14/1989 | EP0320148A1 Analogs of fibroblast growth factor |
| 06/14/1989 | EP0320118A2 Peptides with collagenase inhibiting activity |
| 06/14/1989 | EP0319815A2 Transfectant cell lines which express the major human rhinovirus receptor |
| 06/14/1989 | EP0319664A1 Soluble, iron-containing polypeptide derivatives, their preparation and pharmaceutical uses |
| 06/13/1989 | US4839466 For analysis and treatment of diabetic disorders |
| 06/13/1989 | US4839465 Substance p antagonist, hypotensive agent, analgesics |
| 06/13/1989 | US4839344 Polypeptide compounds having growth hormone releasing activity |
| 06/13/1989 | US4839343 Preparation containing hexatriacontapeptides and methods of use |
| 06/13/1989 | US4839342 Method of increasing tear production by topical administration of cyclosporin |
| 06/13/1989 | US4839341 Stabilized insulin formulations |
| 06/13/1989 | US4839288 Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
| 06/13/1989 | US4839172 Composition of accelerating recovery of function of hematopoietic organs |
| 06/13/1989 | US4839171 Composition for treating impaired lactation |
| 06/13/1989 | US4839170 Administering methylamine, hydroxylamine or the nontoxic hydrochlorides intramuscularly |
| 06/13/1989 | US4839169 Blood clot removal and inhibition |
| 06/13/1989 | EP0246307A4 Cys codon-modified dna. |
| 06/13/1989 | CA1255850A1 Peptides with disulfide bridges and method |
| 06/13/1989 | CA1255849A1 Method for separating polypeptides |
| 06/13/1989 | CA1255588A1 Chemically modified lymphokine and production thereof |
| 06/08/1989 | DE3741606C1 Verfahren zur Erzeugung syngener Zellen und deren Verwendung A method for generating syngeneic cells and their use |
| 06/08/1989 | DE3740520A1 Rapid process for obtaining a factor VII preparation and its use |
| 06/07/1989 | EP0319506A2 Novel platelet-aggregation inhibitor peptide derivatives |
| 06/07/1989 | EP0319333A2 Method for the prevention of graft versus host disease |
| 06/07/1989 | EP0319315A2 The von Willebrand factor binding domain of factor VIII |
| 06/07/1989 | EP0319052A2 Mutant acidic fibroblast growth factor |
| 06/07/1989 | EP0319049A2 Growth hormone analogs, pharmaceutical and veterinary compositions containing said analogs and methods for production thereof |
| 06/07/1989 | EP0319012A2 Immobilized interleukin 2 and interleukin 2 containing a carboxyl-terminal extension |
| 06/07/1989 | EP0318801A2 Preparation to prevent adhesion of organs and organ parts |
| 06/07/1989 | EP0318765A1 A modified gamma interferon dna sequences encoding it and process for producing it |
| 06/07/1989 | EP0318680A2 Novel antibiotic compounds named A/16686 Factors A'1, A'2 and A'3 |
| 06/07/1989 | EP0318512A1 Delivery systems for pharmacological agents |
| 06/07/1989 | CN1033289A Preparation of monostrepurokinase |
| 06/07/1989 | CN1033242A Method for decrease histic damage of imflammation region by monoclone antibody |
| 06/06/1989 | US4837381 Compositions for parenteral administration and their use |
| 06/06/1989 | US4837380 Liposome-calcitonin preparation |
| 06/06/1989 | US4837379 Fibrin-collagen tissue equivalents and methods for preparation thereof |
| 06/06/1989 | US4837306 Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen |
| 06/06/1989 | US4837304 Oligopeptide containing a d-amino acid |
| 06/06/1989 | US4837303 Novel somatostatin derivatives |
| 06/06/1989 | US4837208 Treatment of human viral infections |
| 06/06/1989 | US4837204 Renin inhibitors; hypotensive agents |
| 06/06/1989 | US4837203 Peptide antiasthmatic agents |
| 06/06/1989 | US4837202 Administering somatotropin and prolactin |
| 06/06/1989 | US4837024 Suspension of collagen fibers and glycosaminoglycan on carrier |
| 06/06/1989 | US4837023 Compositions containing hexadecylophosphocholine and alkylglycerols and uses thereof |
| 06/06/1989 | US4837022 Composition containing tissue plasminogen activator |
| 06/06/1989 | US4837017 Induces antibody formation in animals |
| 06/06/1989 | US4837014 With fibrinolytic enzymes and ethylene oxide-propylene oxide c opolymer surfactant |
| 06/06/1989 | CA1255221A1 Synergistic antiviral composition |
| 06/06/1989 | CA1255220A1 Highly solubilized protein and production thereof |
| 06/01/1989 | WO1989004875A2 Characterization and detection of sequences associated with autoimmune diseases |
| 06/01/1989 | WO1989004872A1 Immunoreactive heterochain antibodies |
| 06/01/1989 | WO1989004839A1 Improved ricin molecules and ricin toxin conjugates |
| 06/01/1989 | WO1989004837A1 Protein homologue of human angiogenine |
| 06/01/1989 | WO1989004836A1 Neutrophil-activating factor |
| 06/01/1989 | WO1989004835A1 HUMAN RESPIRATORY SYNCYTIALVIRUS VACCINE DERIVED FROM THE 1A (9.5 kD) PROTEIN |
| 06/01/1989 | WO1989004834A1 Immunoglobulin e competitor |
| 06/01/1989 | WO1989004833A1 Renin inhibiting peptides that contain amino and hydroxy dicarboxylic acids |
| 06/01/1989 | WO1989004832A1 Analogs of fibroblast growth factor |
| 06/01/1989 | WO1989004675A1 Selective removal of immune complexes |
| 06/01/1989 | WO1989004671A1 Differential delivery of therapeutic agents across the blood brain barrier |
| 06/01/1989 | WO1989004668A1 Potentiation of erythropoiesis |
| 06/01/1989 | WO1989004667A1 Agent for prophylaxis and treatment of virally infected diseases |
| 06/01/1989 | WO1989004666A1 Treatment of cancer with somatostatin and analogs thereof |
| 06/01/1989 | WO1989004665A2 Treatment of infections caused by a primary immunodeficiency with interleukin-2 |
| 06/01/1989 | WO1989004664A1 Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| 06/01/1989 | WO1989003396A3 Antibodies to natural killer cell and non-specific cytotoxic cell receptor |
| 06/01/1989 | DE3737274A1 Use of pure H2A and/or H2B histone as active substance for the production of pharmaceutical compositions |
| 05/31/1989 | EP0318451A2 DNA clone of human tissue factor inhibitor |
| 05/31/1989 | EP0318446A1 Amino acid composition for parenteral nutritional support |
| 05/31/1989 | EP0318377A2 Enantiomeric derivatives of amino acids, process for their preparation and their pharmaceutical applications |
| 05/31/1989 | EP0318330A2 Glutathione esters for treating ventricular arrhythmia |
| 05/31/1989 | EP0318302A1 Proteinaceous compositions |
| 05/31/1989 | EP0318296A2 Interleukin-1 receptors |
| 05/31/1989 | EP0318254A2 Tripeptide derivatives |
| 05/31/1989 | EP0318201A2 Inhibition of arterial thrombotic occlusion or thromboembolism |
| 05/31/1989 | EP0318184A1 Acceleration of bone formation with GM-CSF |
| 05/31/1989 | EP0318146A1 Antibiotic solutions and the lyophilization thereof |
| 05/31/1989 | EP0318081A1 Stabilization of antibodies |
| 05/31/1989 | EP0318030A1 Glycoprotein, preparation method, pharmaceutical compositions comprising it and use |
| 05/31/1989 | EP0317956A2 Anti-tumor prodrugs |
| 05/31/1989 | EP0317878A1 Stabilized pharmaceutical agents, process for preparing them, and stable pharmaceutical preparations |
| 05/31/1989 | EP0317641A1 Fused protein containing lymphotoxin |